about
Relationships between obesity, glycemic control, and cardiovascular risk factors: a pooled analysis of cross-sectional data from Spanish patients with type 2 diabetes in the preinsulin stageInitial and subsequent therapy for newly diagnosed type 2 diabetes patients treated in primary care using data from a vendor-based electronic health record.Screening for type 2 diabetes in a multiethnic setting using known risk factors to identify those at high risk: a cross-sectional studyIntracellular adhesion molecule-1 K469E gene polymorphism and risk of diabetic microvascular complications: a meta-analysisDifferential pharmacology and benefit/risk of azilsartan compared to other sartansEffects of Acute Ingestion of Native Banana Starch on Glycemic Response Evaluated by Continuous Glucose Monitoring in Obese and Lean Subjects.Matrix Metalloproteinase 9 Gene Promoter (rs 3918242) Mutation Reduces the Risk of Diabetic Microvascular Complications.Advances in the treatment of prediabetes.Prediabetes: the importance of early identification and intervention.Blockade of receptor activator of nuclear factor-κB (RANKL) signaling improves hepatic insulin resistance and prevents development of diabetes mellitus.Point: postprandial glucose levels are a clinically important treatment target.Cannabinoid 1 G protein-coupled receptor (periphero-)neutral antagonists: emerging therapeutics for treating obesity-driven metabolic disease and reducing cardiovascular risk.Optimizing lipid-lowering therapy in the prevention of coronary heart disease.Hemoglobin A1c as a diagnostic tool: public health implications from an actor-network perspectiveCardiovascular Disease and Diabetes: Two Sides of the Same Coin!
P2860
Q30866303-C3A3ACCF-17C6-45F8-BD92-4F66509E4F98Q34129085-09B5525C-F5C6-47D4-939A-96D07C8CC6ACQ34187545-5FE83E8E-DA98-4867-A32B-C7122FF1B420Q34904925-566933C0-7AA0-4B6E-8980-DF20B9B8F04AQ35808748-E8EA2AE0-279F-4739-969C-C6F68F1998F9Q35890886-310CCE7D-1851-4478-86D0-9A5A9303B891Q35891015-9656F3E6-0A57-461A-9E76-903B088452BEQ36327944-A7B5C3F6-402E-448B-A9E8-DA66BD240691Q37777010-6A0EF93C-961B-4E59-BF24-F1859C21137BQ39197051-FB720961-C03E-40F6-972A-C3D34114A1BDQ42707636-899CA8EF-BC94-4A2F-8499-EA728FA960F3Q45288843-9D770833-6AF6-4404-974B-A26C67F52369Q53168850-B25B6370-2F6B-4721-9FD8-4DFEDE9F6715Q57524890-0B202C33-3581-40D0-91D3-5CC78838879EQ57931390-57934CDE-5DA0-4E52-9C4F-8C703E41C83C
P2860
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh-hant
name
Navigating the choices for diabetes prevention.
@en
Navigating the choices for diabetes prevention.
@nl
type
label
Navigating the choices for diabetes prevention.
@en
Navigating the choices for diabetes prevention.
@nl
prefLabel
Navigating the choices for diabetes prevention.
@en
Navigating the choices for diabetes prevention.
@nl
P356
P1476
Navigating the choices for diabetes prevention.
@en
P2093
David M Nathan
P304
P356
10.1056/NEJME1002322
P407
P577
2010-03-14T00:00:00Z